Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Clin Oral Implants Res ; 29(10): 1038-1049, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30267433

RESUMO

OBJECTIVE: This histomorphometric study compared bone regeneration potential of beta-tricalcium phosphate with fibronectin (ß-TCP-Fn) in critical-sized calvarial defects (CSDs) in rats to assess whether fibronectin (Fn) improved new bone formation. MATERIAL AND METHODS: Critical-sized calvarial defects were created in 30 adult male Sprague Dawley rats, which were divided into four groups according to the time of euthanasia (6 or 8 weeks of healing) and type of filling (ß-TCP-Fn/6 weeks, ß-TCP/6 weeks, ß-TCP-Fn/8 weeks and ß-TCP/8 weeks). The primary variables related to new bone formation were augmented area (AA) and gained tissue (GT; sum of mineralized bone matrix [MBM] and bone substitute [BS]). Secondary variables were the diameter of the defect, MBM, non-mineralized tissue (NMT) and BS. RESULTS: A total of 29 rats and 58 histological samples were evaluated, 28 (48.3%) samples obtained at 6 weeks and 30 (51.7%) at 8 weeks, homogeneously distributed between right and left sides. Thirteen (22.4%) were treated with ß-TCP-Fn, 16 (27.6%) with ß-TCP and 29 (50%) were controls. At 8 weeks, histomorphometric analysis showed significant differences in AA using ß-TCP and ß-TCP-Fn versus controls (p = 0.001 and p = 0.005, respectively). Bone turnover expressed as % within the target area was slightly higher but not statistically significant in the ß-TCP-Fn than in ß-TCP (MBM) at 6 weeks versus 8 weeks (p = 0.067 and p = 0.335, respectively). Finally, the total GT area in mm2 was higher using ß-TCP-Fn as compared to ß-TCP (p = 0.044). CONCLUSIONS: ß-TCP-Fn was slightly but non-significantly more effective than ß-TCP without Fn for improving the volume of regenerated bone in CSDs of rats, possibly allowing a more efficient bone remodelling process. This effect however should continue being investigated.


Assuntos
Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Fibronectinas/uso terapêutico , Regeneração Tecidual Guiada/métodos , Animais , Regeneração Óssea/efeitos dos fármacos , Masculino , Ratos , Ratos Sprague-Dawley , Crânio/fisiologia , Crânio/cirurgia
2.
Int J Oral Maxillofac Implants ; 32(2): e97-e106, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28291861

RESUMO

PURPOSE: To determine the bone regeneration potential of a ceramic biomaterial coated with fibronectin and adipose-derived stem cells covered in three-wall critical-size defects associated with dental implants. MATERIALS AND METHODS: In a total of 18 dogs, four dehiscence-type and critical-size defects were created surgically in the edentulous alveolar ridge with the simultaneous placement of dental implants. Defects were randomly regenerated using biomaterials coated with particulate ß-tricalcium phosphate (ß-TCP), ß-TCP with fibronectin (Fn) (ß-TCP-Fn), and ß-TCP with a combination of Fn and autologous adipose-derived stem cells (ADSCs) (ß-TCP-Fn-ADSCs), leaving one defect as the control. The animals were divided into three groups according to the time of euthanasia (1, 2, or 3 months). RESULTS: Statistically significant differences between the three study groups (ß-TCP, ß-TCP-Fn, ß-TCP-Fn-ADSCs) and the control group in the total area of bone regeneration and mineralized and nonmineralized tissue at 1, 2, and 3 months of healing were not observed. At 2 months, defects treated with ß-TCP-Fn-ADSCs showed a significant decrease in the percentage of bone-to-implant contact (BIC) as compared with the ß-TCP-Fn (P = .041) and control (P = .012) groups. At 3 months of healing, however, significant differences in BIC between the three study groups and controls were not found (P = .388). CONCLUSION: The use of ADSCs in the bone regeneration processes of dehiscencetype defects associated with simultaneous implant insertion does not seem to improve the area of bone regeneration or the percentage of BIC compared with other biomaterials or the control alveolar defect.


Assuntos
Tecido Adiposo/citologia , Perda do Osso Alveolar/terapia , Materiais Biocompatíveis/uso terapêutico , Regeneração Óssea/fisiologia , Implantação Dentária Endóssea/métodos , Fibronectinas/uso terapêutico , Transplante de Células-Tronco/métodos , Processo Alveolar/cirurgia , Animais , Fosfatos de Cálcio/uso terapêutico , Cerâmica , Implantes Dentários , Modelos Animais de Doenças , Cães , Feminino , Implantes Experimentais , Células-Tronco , Cicatrização/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...